abstract |
The present invention provides sulfooxyalkylorganonitro and related compounds, compositions containing these compounds and methods of using these compounds and compositions to treat medical disorders such as neurodegenerative disorders, autoimmune diseases, infections or cancer in a patient. Exemplary sulfooxyalkyl organonitro compounds described herein include ((2-(3,3-dinitroazetidin-1-yl)-2-oxyethyl)sulfinyl)- D-alanine and its variants. |